| LCTX Stock | | | USD 0.50 0.10 16.67% |
Lineage Cell financial indicator trend analysis is infinitely more than just investigating Lineage Cell Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lineage Cell Therapeutics is a good investment. Please check the relationship between Lineage Cell Operating Income and its Gross Profit accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lineage Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Operating Income vs Gross Profit
Operating Income vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lineage Cell Therapeutics Operating Income account and
Gross Profit. At this time, the significance of the direction appears to have very week relationship.
The correlation between Lineage Cell's Operating Income and Gross Profit is 0.28. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Lineage Cell Therapeutics, assuming nothing else is changed. The correlation between historical values of Lineage Cell's Operating Income and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Lineage Cell Therapeutics are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Operating Income i.e., Lineage Cell's Operating Income and Gross Profit go up and down completely randomly.
Correlation Coefficient | 0.28 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Operating Income
Operating Income is the amount of profit realized from Lineage Cell Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Lineage Cell Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Lineage Cell Therapeutics minus its cost of goods sold. It is profit before Lineage Cell operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most indicators from Lineage Cell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lineage Cell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lineage Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
At this time, Lineage Cell's
Issuance Of Capital Stock is fairly stable compared to the past year.
Enterprise Value is likely to rise to about 206.5
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 11
M in 2024.
Lineage Cell fundamental ratios Correlations
Click cells to compare fundamentals
Lineage Cell Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lineage Cell fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to
measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to
predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.